The Effects of Auditory Stimulation During Sleep on Brain Networks in Schizophrenia

NCT ID: NCT06386588

Last Updated: 2025-05-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-02-05

Study Completion Date

2027-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In this research study the investigators will use sleep headbands to measure brain rhythms and to improve their coordination across brain regions. The headbands will be worn at home for multiple nights. On some nights the headbands will play soft sounds at specific times during sleep. The investigators are interested in learning whether this timed auditory stimulation may be a strategy to improve the coordination of sleep rhythms across brain regions, improve network communication, and as a result, improve memory. The investigators will study 30 adults aged 18-45 with schizophrenia and 30 demographically matched healthy controls. Participants will first have a daytime MRI scan, during which they will complete a finger tapping motor sequence task (MST), followed by a week of sleep at home with a sleep headband. They will also do the MST at home on two of the nights. On the final day of the study, participants will return for a second MRI scan.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Schizophrenia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Schizophrenia

Adult outpatients with a diagnosis of schizophrenia.

Group Type EXPERIMENTAL

Closed loop auditory stimulation during sleep

Intervention Type OTHER

Short bursts of pink noise delivered at precise times during overnight sleep at home.

Healthy Controls

Adult participants screened to exclude a personal history of mental illness, family history of schizophrenia spectrum disorder, and psychoactive medication use.

Group Type ACTIVE_COMPARATOR

Closed loop auditory stimulation during sleep

Intervention Type OTHER

Short bursts of pink noise delivered at precise times during overnight sleep at home.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Closed loop auditory stimulation during sleep

Short bursts of pink noise delivered at precise times during overnight sleep at home.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18-45 years old
* Fluent in English
* Able to give informed consent

Additional inclusion for Adults with schizophrenia:

* A DSM-V confirmed diagnosis of schizophrenia
* Unmedicated or maintained on a stable dose of APDs

Exclusion Criteria

* Ferrous metal in the body
* Currently pregnant or breastfeeding
* Motor problems that preclude finger tapping task
* IQ \<85
* Other neurological disorders, including seizure disorder
* Significant hearing or vision loss
* Chronic medical conditions that affect sleep
* Unstable chronic medical condition such as asthma, diabetes, cystic fibrosis, or cardiac disease
* Diagnosed sleep disorder, except insomnia
* History of head injury resulting in prolonged loss of consciousness or other neurological sequelae


* History of mental illness
* Current use of psychotropic medications or treatment with medications known to affect sleep or cognition
Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Massachusetts General Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Dara S. Manoach, PhD

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Massachusetts General Hospital

Charlestown, Massachusetts, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Lindsey Jones, MS

Role: CONTACT

617-702-2368

Dara Manoach, PhD

Role: CONTACT

617-724-6148

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Dara Manoach, PhD

Role: primary

617-724-6148

Lindsey Jones, MS

Role: backup

617-702-2368

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2024P000610

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Externalization and Stimulation
NCT05936307 UNKNOWN NA